Protega Pharmaceuticals™ LLC Announces Commercialization of RoxyBond™ (oxycodone hydrochloride) Tablets CII in the U.S.
06 juil. 2022 08h00 HE
|
Protega Pharmaceuticals LLC
RoxyBond is the first and only immediate-release opioid medication with FDA-approved labeling describing abuse-deterrent properties.1 PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Protega...